Differential involvement of nigral subregions in idiopathic parkinson's disease
暂无分享,去创建一个
Eung Yeop Kim | Jongho Lee | Hyeong-Geol Shin | Yoonho Nam | Young Hee Sung | Young Noh | E. Kim | Jongho Lee | Y. Nam | Dong Hoon Shin | Y. Sung | Y. Noh | Hyeong-Geol Shin | D. Shin
[1] F. Yang,et al. Universality analysis of the existence of substantia nigra "swallow tail" appearance of non-Parkinson patients in 3T SWI. , 2016, European review for medical and pharmacological sciences.
[2] J S Thornton,et al. 9.4T MR microscopy of the substantia nigra with pathological validation in controls and disease. , 2017, NeuroImage. Clinical.
[3] Ji Young Yun,et al. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECT , 2016, Movement disorders : official journal of the Movement Disorder Society.
[4] M. Tosetti,et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. , 2014, Radiology.
[5] C Strand,et al. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease , 2016, NeuroImage: Clinical.
[6] H J Gundersen,et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[7] D. Mash,et al. Dopaminergic innervation of the human striatum in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[8] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[9] W. Poewe,et al. Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.
[10] O. Hornykiewicz,et al. The discovery of dopamine deficiency in the parkinsonian brain. , 2006, Journal of neural transmission. Supplementum.
[11] J. J. Lee,et al. Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism. , 2016, AJR. American journal of roentgenology.
[12] E. Kim,et al. Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging. , 2016, Radiology.
[13] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[14] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[15] R. Bowtell,et al. Visualization of nigrosome 1 and its loss in PD , 2013, Neurology.
[16] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[17] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[18] M. Tosetti,et al. Comparison of 3T and 7T Susceptibility-Weighted Angiography of the Substantia Nigra in Diagnosing Parkinson Disease , 2015, American Journal of Neuroradiology.
[19] Klaus Seppi,et al. Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7T MRI , 2014, Neurology.
[20] J. Lee,et al. Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality , 2015, American Journal of Neuroradiology.
[21] M. Tosetti,et al. Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI , 2016, Journal of Neural Transmission.
[22] N. Wang,et al. Using ‘swallow-tail’ sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson’s disease: A susceptibility-weighted imaging study , 2017, European Radiology.
[23] Dong-Hyun Kim,et al. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map‐weighted imaging (SMWI) , 2017, Journal of magnetic resonance imaging : JMRI.
[24] A. van Cappellen van Walsum,et al. Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study , 2016, Polish journal of radiology.
[25] S. Gacinovic,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.
[26] Dorothee P. Auer,et al. The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T , 2014, PloS one.
[27] T. Simuni,et al. Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes? , 2017, Clinical imaging.
[28] S. Kang,et al. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. , 2016, Parkinsonism & related disorders.
[29] Z. Cho,et al. Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease , 2012, Annals of neurology.
[30] Martin Styner,et al. Imaging nigral pathology and clinical progression in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[31] Michael Schocke,et al. Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative Parkinsonism , 2015, Movement disorders : official journal of the Movement Disorder Society.
[32] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.